<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(2)</volume><submitter>Kim R</submitter><funding>Institut National Du Cancer (INCa)</funding><funding>Institut National Du Cancer</funding><pubmed_abstract>Low hypodiploidy defines a rare subtype of B-cell acute lymphoblastic leukemia (B-ALL) with a dismal outcome. To investigate the genomic basis of low-hypodiploid ALL (LH-ALL) in adults, we analyzed copy-number aberrations, loss of heterozygosity, mutations, and cytogenetics data in a prospective cohort of Philadelphia (Ph)-negative B-ALL patients (n = 591, ages 18-84 years), allowing us to identify 80 LH-ALL cases (14%). Genomic analysis was critical for evidencing low hypodiploidy in many cases missed by cytogenetics. The proportion of LH-ALL within Ph-negative B-ALL dramatically increased with age, from 3% in the youngest patients (under 40 years old) to 32% in the oldest (over 55 years old). Somatic TP53 biallelic inactivation was the hallmark of adult LH-ALL, present in virtually all cases (98%). Strikingly, we detected TP53 mutations in posttreatment remission samples in 34% of patients. Single-cell proteogenomics of diagnosis and remission bone marrow samples evidenced a preleukemic, multilineage, TP53-mutant clone, reminiscent of age-related clonal hematopoiesis.&lt;h4>Significance&lt;/h4>We show that low-hypodiploid ALL is a frequent entity within B-ALL in older adults, relying on somatic TP53 biallelic alteration. Our study unveils a link between aging and low-hypodiploid ALL, with TP53-mutant clonal hematopoiesis representing a preleukemic reservoir that can give rise to aneuploidy and B-ALL. See related commentary by Saiki and Ogawa, p. 102. This article is highlighted in the In This Issue feature, p. 101.</pubmed_abstract><journal>Blood cancer discovery</journal><pagination>134-149</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9975768</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.</pubmed_title><pmcid>PMC9975768</pmcid><pubmed_authors>Lheritier V</pubmed_authors><pubmed_authors>Delabesse E</pubmed_authors><pubmed_authors>Huguet F</pubmed_authors><pubmed_authors>Dombret H</pubmed_authors><pubmed_authors>Soulier J</pubmed_authors><pubmed_authors>Cuccuini W</pubmed_authors><pubmed_authors>Ades L</pubmed_authors><pubmed_authors>Gachet S</pubmed_authors><pubmed_authors>Grardel N</pubmed_authors><pubmed_authors>Graux C</pubmed_authors><pubmed_authors>Passet M</pubmed_authors><pubmed_authors>Chevallier P</pubmed_authors><pubmed_authors>Pastoret C</pubmed_authors><pubmed_authors>Lafage-Pochitaloff M</pubmed_authors><pubmed_authors>Leguay T</pubmed_authors><pubmed_authors>Schafer BW</pubmed_authors><pubmed_authors>Bergugnat H</pubmed_authors><pubmed_authors>Rousselot P</pubmed_authors><pubmed_authors>Boissel N</pubmed_authors><pubmed_authors>Asnafi V</pubmed_authors><pubmed_authors>Hicheri Y</pubmed_authors><pubmed_authors>Kim R</pubmed_authors><pubmed_authors>Hunault M</pubmed_authors><pubmed_authors>Itzykson R</pubmed_authors><pubmed_authors>Duchmann M</pubmed_authors><pubmed_authors>Larcher L</pubmed_authors><pubmed_authors>Clappier E</pubmed_authors><pubmed_authors>Chalandon Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.</name><description>Low hypodiploidy defines a rare subtype of B-cell acute lymphoblastic leukemia (B-ALL) with a dismal outcome. To investigate the genomic basis of low-hypodiploid ALL (LH-ALL) in adults, we analyzed copy-number aberrations, loss of heterozygosity, mutations, and cytogenetics data in a prospective cohort of Philadelphia (Ph)-negative B-ALL patients (n = 591, ages 18-84 years), allowing us to identify 80 LH-ALL cases (14%). Genomic analysis was critical for evidencing low hypodiploidy in many cases missed by cytogenetics. The proportion of LH-ALL within Ph-negative B-ALL dramatically increased with age, from 3% in the youngest patients (under 40 years old) to 32% in the oldest (over 55 years old). Somatic TP53 biallelic inactivation was the hallmark of adult LH-ALL, present in virtually all cases (98%). Strikingly, we detected TP53 mutations in posttreatment remission samples in 34% of patients. Single-cell proteogenomics of diagnosis and remission bone marrow samples evidenced a preleukemic, multilineage, TP53-mutant clone, reminiscent of age-related clonal hematopoiesis.&lt;h4>Significance&lt;/h4>We show that low-hypodiploid ALL is a frequent entity within B-ALL in older adults, relying on somatic TP53 biallelic alteration. Our study unveils a link between aging and low-hypodiploid ALL, with TP53-mutant clonal hematopoiesis representing a preleukemic reservoir that can give rise to aneuploidy and B-ALL. See related commentary by Saiki and Ogawa, p. 102. This article is highlighted in the In This Issue feature, p. 101.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2026-05-29T07:44:27.112Z</modification><creation>2025-02-19T01:18:03.717Z</creation></dates><accession>S-EPMC9975768</accession><cross_references><pubmed>36630200</pubmed><doi>10.1158/2643-3230.BCD-22-0154</doi></cross_references></HashMap>